维普中文期刊产品整合服务
44篇 您的检索式:作者名="AREND S M"
    题名 作者 年代 出处 被引量
1补体B因子是代谢综合征模型代谢与心血管特征的一个决定因素显示文摘补体B因子(complenment factor B,CFB)在2型糖尿病及心血管病患者脂肪组织及血清中水平升高,但与疾病发病机制的因果关系不明确。自发性高血压大鼠(spontaneously hypertensive rats,SHR)脂肪组织及血清中CFB也升高。为明确CFB在代谢综合征中的作用,研究者在SHR中敲除Cfb基因。赵狄 练桂丽 Coan PM Barrier M Alfazema N Carter RN Marion de Procé S Dopico XC Garcia Diaz A Thomson A Jackson-Jones LH Moyon B Webster Z Ross D Moss J Arends MJ Morton NM Aitman TJ 2017中华高血压杂志2017,25,8:3
2Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients-results of a phase Ⅱ study显示文摘Steinbild S Arends J Medinger M 2007Onkologie2007,30,12:1
3Use of ESAT-6 and CFP-1 0 antigens for diagnosis of extrapulmonary tuberculosis显示文摘Munk M E Arend S M Brock I 2001J Infect Dis2001,183,:1
4Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts 显示文摘Kik SV Franken WP Mensen M Cobelens FG Kamphorst M Arend SM Erkens C Gebhard A Borgdorff MW Verver S 2010Eur Respir J2010,35,6:1
5Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients-results of a phase Ⅱ study 显示文摘Steinbild S Arends J Medinger M 2007Onkologie2007,30,12:1
6Patient survival after renal transplantation: more than 25 years follow-up 显示文摘AREND S M MALLAT M J WESTENDORP R J 1997Nephrol Dial Transplantation1997,12,8:1
7Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filt rate protein 10 and to mixtures of synthetic peptides显示文摘Arend S M Geluk A Meijgaarden K E 2000Infect Immun2000,68,6:1
8Patient survival after renal transplantation; more than 25 years follow-up显示文摘Arend S M Mallat M J Westendorp R J 1997Nephrol Dial Transplant1997,12,:1
9Health-related quality of life and its determinants in Parkinson' s disease : results of an Italian cohort study显示文摘Winter Y yon Campenhausen S Arend M 2011Parkinsonism Relat Disord2011,17,4:1
10Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after anti- biotic treatment显示文摘DIELEMAN L A GOERRES M S ARENDS A 2003Gut2003,52,3:1
11Metronomic antiangiogenie therapy with capeeitahine and celecoxib in advanced tumor patients--results of a phase Ⅱ study 显示文摘Steinbild S Arends J Medinger M 2007Onkologie2007,30,12:1
12Metmnomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients results of a phase II study显示文摘Steinbild S Arends J Medinger M 2007Onkologie2007,30,12:1
13Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients results of a phase Ⅱ study显示文摘Steinbild S Arends J Medinger M 2007Onkologie2007,30,12:1
14Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kd protein and culture filtrate protein 10显示文摘Arend S M Geluk A VanMeijgaarden K E 2000J Infect Dis2000,181,10:1
15Health-related quality of life and its determinants in Parkinson disease:results of an Italian cohort study 显示文摘Winter Y Campenhausen S Arend M 2011Parkinsonism &Related Disorders2011,17,4:1
16Metronomic antiangio- genic therapy with capecitabine and celecoxib in advanced tumor pa- tients-results of a phase I1 study 显示文摘Steinbild S Arends J Medinger M 2007Onkologie2007,30,12:1
17Health-related quality oflife and its determinants in Parkinson's disease: results of an Italian cohort study显示文摘Winter Y von Campenhausen S Arend M 2011Parkinsonism & Related Disorders2011,17,4:1
18Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact显示文摘Arend S M Engelhard A C Groot G 2001Clin Diagn Lab Immunol2001,8,6:1
19Health-related quality of life and its determinants in Parkinson's disease: results of an Italian cohort study 显示文摘Winter Y von Campenhausen S Arend M 2011Parkinsonism Relat Disord2011,17,4:1
20Metronomic anti-angiogenic therapy with capecitabine and celeeoxib in advanced tumor patients-results of a phase II study显示文摘STEINBILD S ARENDS J MEDINQER M 2007Onkologie2007,30,12:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费